Timing of antiviral treatment initiation is critical to reduce SARS-Cov-2 viral load
Antonio Gonçalves, Julie Bertrand, Ruian Ke, Emmanuelle Comets, Xavier de Lamballerie, Denis Malvy, Andrés Pizzorno, Olivier Terrier, Manuel Rosa Calatrava, France Mentré, Patrick Smith, Alan S Perelson, Jérémie Guedj
doi: https://doi.org/10.1101/2020.04.04.20047886
Antonio Gonçalves
1Université de Paris, IAME, INSERM, F-75018 Paris, France
Julie Bertrand
1Université de Paris, IAME, INSERM, F-75018 Paris, France
Ruian Ke
2Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
Emmanuelle Comets
1Université de Paris, IAME, INSERM, F-75018 Paris, France
Xavier de Lamballerie
3UMR “Emergence des Pathologies Virales” (EPV: Aix-Marseille University - IRD 190 - Inserm 1207 - EHESP) - Institut Hospitalo-Universitaire Méditerranée Infection, F-13385 Marseille, France
Denis Malvy
4Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France
5Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
Andrés Pizzorno
6CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France
Olivier Terrier
6CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France
Manuel Rosa Calatrava
6CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France
France Mentré
1Université de Paris, IAME, INSERM, F-75018 Paris, France
Patrick Smith
7Certara, Integrated Drug Development, Princeton, NJ, USA
Alan S Perelson
2Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
Jérémie Guedj
1Université de Paris, IAME, INSERM, F-75018 Paris, France
Posted June 21, 2020.
Timing of antiviral treatment initiation is critical to reduce SARS-Cov-2 viral load
Antonio Gonçalves, Julie Bertrand, Ruian Ke, Emmanuelle Comets, Xavier de Lamballerie, Denis Malvy, Andrés Pizzorno, Olivier Terrier, Manuel Rosa Calatrava, France Mentré, Patrick Smith, Alan S Perelson, Jérémie Guedj
medRxiv 2020.04.04.20047886; doi: https://doi.org/10.1101/2020.04.04.20047886
Timing of antiviral treatment initiation is critical to reduce SARS-Cov-2 viral load
Antonio Gonçalves, Julie Bertrand, Ruian Ke, Emmanuelle Comets, Xavier de Lamballerie, Denis Malvy, Andrés Pizzorno, Olivier Terrier, Manuel Rosa Calatrava, France Mentré, Patrick Smith, Alan S Perelson, Jérémie Guedj
medRxiv 2020.04.04.20047886; doi: https://doi.org/10.1101/2020.04.04.20047886
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (670)
- Anesthesia (181)
- Cardiovascular Medicine (2654)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12245)
- Forensic Medicine (10)
- Gastroenterology (762)
- Genetic and Genomic Medicine (4113)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2665)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (853)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6538)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)